COLL vs. ^GSPC

In the year-to-date period, COLL achieves a 1.71% return, which is significantly higher than ^GSPC's 0.51% return. Over the past 10 years, COLL has underperformed ^GSPC with an annualized return of 5.21%, while ^GSPC has yielded a comparatively higher 10.85% annualized return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Collegium Pharmaceutical, Inc. (COLL) and S&P 500 (^GSPC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current COLL Sharpe Ratio is -0.26, which is lower than the ^GSPC Sharpe Ratio of 0.66. The chart below compares the historical Sharpe Ratios of COLL and ^GSPC, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

The maximum COLL drawdown since its inception was -73.59%, which is greater than ^GSPC's maximum drawdown of -56.78%. Use the drawdown chart below to compare losses from any high point for COLL and ^GSPC.

Collegium Pharmaceutical, Inc. (COLL) has a higher volatility of 9.41% compared to S&P 500 (^GSPC) at 4.77%. This indicates that COLL's price experiences larger fluctuations and is considered to be riskier than ^GSPC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.